サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1467728

ヒト成長ホルモン市場レポート：用途、流通チャネル、投与経路、地域別、2024～2032年

Human Growth Hormone Market Report by Application, Distribution Channel, Route of Administration, and Region 2024-2032

出版日
発行
IMARC
ページ情報
英文 136 Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.99円
ヒト成長ホルモン市場レポート：用途、流通チャネル、投与経路、地域別、2024～2032年
出版日: 2024年04月08日
発行: IMARC
ページ情報: 英文 136 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

ヒト成長ホルモンの世界市場規模は2023年に57億米ドルに達しました。今後、IMARC Groupは、市場が2032年までに109億米ドルに達し、2024～2032年の間に7.2%の成長率（CAGR）を示すと予測しています。

HGHは下垂体から分泌されるペプチドホルモンで、小児と成人の成長を刺激します。このホルモンは主に細胞の成長、再生、修復、再生産、代謝を調節し、身体の全体的な発達に寄与します。また、体液、脂肪代謝、骨や筋肉の成長も調節します。HGHが欠乏すると病気や脂肪蓄積のリスクが高まるが、高濃度になると小児では巨大症、成人では先端巨大症、筋肉衰弱症、短腸症候群を引き起こす可能性があります。

ターナー症候群やその他の成長関連疾患の有病率の増加は、市場の成長を促進する主要要因の一つです。ターナー症候群は、主に女性が罹患する染色体異常で、X染色体の完全または部分的な喪失を特徴とします。成長ホルモンは、この疾患の症状の一部を回復させるために投与されることが多く、それによって世界中でHGH医薬品の需要が増加しています。さらに、大衆の間で健康意識が高まり、内分泌疾患の予防措置に関する意識が高まっていることも、市場の成長を後押ししています。プラダー・ウィリー症候群（PWS）や特発性低身長症（ISS）といった様々な疾患は、体内の成長ホルモンの欠乏によって引き起こされるものであり、医療用に合成されたHGHを用いて治療することができます。ボディビルダーによるパフォーマンス向上剤としてのHGHの利用増加や、遺伝子組換えヒト成長ホルモン（rHGH）の市場開拓など、その他の要因も市場をさらに牽引すると予測されます。

本レポートで扱う主要質問

  • ヒト成長ホルモンの世界市場規模は？
  • 2024～2032年の世界ヒト成長ホルモン市場の予想成長率は？
  • ヒト成長ホルモンの世界市場を牽引する主要要因は？
  • COVID-19が世界のヒト成長ホルモン市場に与えた影響は？
  • ヒト成長ホルモンの世界市場の用途別区分は？
  • ヒト成長ホルモンの世界市場における販売チャネル別の区分は？
  • 投与経路別のヒト成長ホルモンの世界市場の内訳は？
  • ヒト成長ホルモンの世界市場における主要地域は？
  • ヒト成長ホルモンの世界市場における主要参入企業は？

目次

第1章 序文

第2章 調査範囲と調査手法

  • 調査目的
  • 利害関係者
  • データソース
    • 一次情報
    • 二次情報
  • 市場推定
    • ボトムアップアプローチ
    • トップダウンアプローチ
  • 調査手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

  • 概要
  • 主要産業動向

第5章 ヒト成長ホルモンの世界市場

  • 市場概要
  • 市場実績
  • COVID-19の影響
  • 市場予測

第6章 市場内訳：用途別

  • 成長ホルモン（GH）欠乏症
    • 市場動向
    • 主要タイプ
      • 成人GH欠乏症
      • 小児GH欠乏症
    • 市場予測
  • ターナー症候群
  • 特発性低身長症（ISS）
  • プラダーウィリー症候群（PWS）
  • 妊娠悪阻
  • その他

第7章 市場内訳：流通チャネル別

  • 病院薬局
  • 小売薬局
  • オンライン薬局
  • その他

第8章 市場内訳：投与経路別

  • 静脈内投与
  • 筋肉内投与
  • 皮下
  • 経口

第9章 市場内訳：地域別

  • 北米
    • 米国
    • カナダ
  • アジア太平洋
    • 中国
    • 日本
    • インド
    • 韓国
    • オーストラリア
    • インドネシア
    • その他
  • 欧州
    • ドイツ
    • フランス
    • 英国
    • イタリア
    • スペイン
    • ロシア
    • その他
  • ラテンアメリカ
    • ブラジル
    • メキシコ
    • その他
  • 中東・アフリカ
    • 市場動向
    • 市場内訳：国別
    • 市場予測

第10章 SWOT分析

  • 概要
  • 強み
  • 弱み
  • 機会
  • 脅威

第11章 バリューチェーン分析

第12章 ポーターのファイブフォース分析

  • 概要
  • 買い手の交渉力
  • 供給企業の交渉力
  • 競合の程度
  • 新規参入業者の脅威
  • 代替品の脅威

第13章 競合情勢

  • 市場構造
  • 主要企業
  • 主要企業のプロファイル
    • Eli Lilly and Company
    • EMD Serono Inc.
    • F. Hoffmann-La Roche AG
    • Ferring B.V.
    • Genentech Inc.
    • Ipsen
    • Merck KGaA
    • Novartis AG
    • Novo Nordisk
    • Pfizer Inc.
    • Sandoz
図表

List of Figures

  • Figure 1: Global: Human Growth Hormone Market: Major Drivers and Challenges
  • Figure 2: Global: Human Growth Hormone Market: Sales Value (in Billion US$), 2018-2023
  • Figure 3: Global: Human Growth Hormone Market: Breakup by Application (in %), 2023
  • Figure 4: Global: Human Growth Hormone Market: Breakup by Distribution Channel (in %), 2023
  • Figure 5: Global: Human Growth Hormone Market: Breakup by Route of Administration (in %), 2023
  • Figure 6: Global: Human Growth Hormone Market: Breakup by Region (in %), 2023
  • Figure 7: Global: Human Growth Hormone Market Forecast: Sales Value (in Billion US$), 2024-2032
  • Figure 8: Global: Human Growth Hormone (Growth Hormone Deficiency) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 9: Global: Human Growth Hormone (Growth Hormone Deficiency) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 10: Global: Human Growth Hormone (Turner Syndrome) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 11: Global: Human Growth Hormone (Turner Syndrome) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 12: Global: Human Growth Hormone (Idiopathic Short Stature- ISS) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 13: Global: Human Growth Hormone (Idiopathic Short Stature- ISS) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 14: Global: Human Growth Hormone (Prader-Willi Syndrome- PWS) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 15: Global: Human Growth Hormone (Prader-Willi Syndrome- PWS) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 16: Global: Human Growth Hormone (Small for Gestational Age) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 17: Global: Human Growth Hormone (Small for Gestational Age) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 18: Global: Human Growth Hormone (Other Applications) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 19: Global: Human Growth Hormone (Other Applications) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 20: Global: Human Growth Hormone (Hospital Pharmacy) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 21: Global: Human Growth Hormone (Hospital Pharmacy) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 22: Global: Human Growth Hormone (Retail Pharmacy) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 23: Global: Human Growth Hormone (Retail Pharmacy) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 24: Global: Human Growth Hormone (Online Pharmacy) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 25: Global: Human Growth Hormone (Online Pharmacy) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 26: Global: Human Growth Hormone (Others) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 27: Global: Human Growth Hormone (Others) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 28: Global: Human Growth Hormone (Intravenous) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 29: Global: Human Growth Hormone (Intravenous) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 30: Global: Human Growth Hormone (Intramuscular) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 31: Global: Human Growth Hormone (Intramuscular) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 32: Global: Human Growth Hormone (Subcutaneous) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 33: Global: Human Growth Hormone (Subcutaneous) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 34: Global: Human Growth Hormone (Oral) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 35: Global: Human Growth Hormone (Oral) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 36: North America: Human Growth Hormone Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 37: North America: Human Growth Hormone Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 38: United States: Human Growth Hormone Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 39: United States: Human Growth Hormone Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 40: Canada: Human Growth Hormone Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 41: Canada: Human Growth Hormone Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 42: Asia Pacific: Human Growth Hormone Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 43: Asia Pacific: Human Growth Hormone Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 44: China: Human Growth Hormone Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 45: China: Human Growth Hormone Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 46: Japan: Human Growth Hormone Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 47: Japan: Human Growth Hormone Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 48: India: Human Growth Hormone Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 49: India: Human Growth Hormone Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 50: South Korea: Human Growth Hormone Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 51: South Korea: Human Growth Hormone Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 52: Australia: Human Growth Hormone Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 53: Australia: Human Growth Hormone Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 54: Indonesia: Human Growth Hormone Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 55: Indonesia: Human Growth Hormone Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 56: Others: Human Growth Hormone Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 57: Others: Human Growth Hormone Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 58: Europe: Human Growth Hormone Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 59: Europe: Human Growth Hormone Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 60: Germany: Human Growth Hormone Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 61: Germany: Human Growth Hormone Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 62: France: Human Growth Hormone Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 63: France: Human Growth Hormone Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 64: United Kingdom: Human Growth Hormone Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 65: United Kingdom: Human Growth Hormone Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 66: Italy: Human Growth Hormone Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 67: Italy: Human Growth Hormone Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 68: Spain: Human Growth Hormone Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 69: Spain: Human Growth Hormone Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 70: Russia: Human Growth Hormone Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 71: Russia: Human Growth Hormone Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 72: Others: Human Growth Hormone Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 73: Others: Human Growth Hormone Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 74: Latin America: Human Growth Hormone Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 75: Latin America: Human Growth Hormone Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 76: Brazil: Human Growth Hormone Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 77: Brazil: Human Growth Hormone Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 78: Mexico: Human Growth Hormone Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 79: Mexico: Human Growth Hormone Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 80: Others: Human Growth Hormone Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 81: Others: Human Growth Hormone Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 82: Middle East and Africa: Human Growth Hormone Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 83: Middle East and Africa: Human Growth Hormone Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 84: Global: Human Growth Hormone Industry: SWOT Analysis
  • Figure 85: Global: Human Growth Hormone Industry: Value Chain Analysis
  • Figure 86: Global: Human Growth Hormone Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Human Growth Hormone Market: Key Industry Highlights, 2023 and 2032
  • Table 2: Global: Human Growth Hormone Market Forecast: Breakup by Application (in Million US$), 2024-2032
  • Table 3: Global: Human Growth Hormone Market Forecast: Breakup by Distribution Channel (in Million US$), 2024-2032
  • Table 4: Global: Human Growth Hormone Market Forecast: Breakup by Route of Administration (in Million US$), 2024-2032
  • Table 5: Global: Human Growth Hormone Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 6: Global: Human Growth Hormone Market: Competitive Structure
  • Table 7: Global: Human Growth Hormone Market: Key Players
目次
Product Code: SR112024A2052

The global human growth hormone market size reached US$ 5.7 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 10.9 Billion by 2032, exhibiting a growth rate (CAGR) of 7.2% during 2024-2032.

HGH is a peptide hormone that is produced by the pituitary gland to stimulate growth in children and adults. The hormone primarily regulates growth, regeneration, repair, reproduction and metabolism of the cells, thus contributing to the overall development of the body. It also regulates body fluids, fat metabolism and bone and muscle growth. The deficiency of HGH can increase the risk of diseases and fat accumulation, whereas higher levels can cause gigantism in children and acromegaly, muscle-wasting disease and short bowel syndrome in adults.

The increasing prevalence of Turner syndrome and other growth-related disorders is one of the key factors driving the growth of the market. Turner syndrome is a chromosomal disorder that primarily affects females and is characterized by complete or partial loss of X chromosomes. Growth hormones are often administered to reverse some of the symptoms of this disease, thereby increasing the demand for HGH drugs across the globe. Furthermore, increasing health consciousness among the masses and growing awareness regarding the preventive measures against endocrine disorders, are providing a boost to the market growth. Various disorders, such as Prader-Willi syndrome (PWS) and idiopathic short stature (ISS), are caused by the deficiency of growth hormones in the body that can be treated using medically synthesized HGH. Other factors, including a rising utilization of HGH as performance enhancers by bodybuilders, along with the development of recombinant human growth hormone (rHGH), are projected to drive the market further.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global human growth hormone market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on application, distribution channel and route of administration.

Breakup by Application:

Growth Hormone (GH) Deficiency

Adult GH Deficiency

Pediatric GH Deficiency

Turner Syndrome

Idiopathic Short Stature (ISS)

Prader-Willi Syndrome (PWS)

Small for Gestational Age

Others

Breakup by Distribution Channel:

Hospital Pharmacy

Retail Pharmacy

Online Pharmacy

Others

Breakup by Route of Administration:

Intravenous

Intramuscular

Subcutaneous

Oral

Breakup by Region:

North America

United States

Canada

Asia Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined with some of the key players being Eli Lilly and Company, EMD Serono Inc., F. Hoffmann-La Roche AG, Ferring B.V., Genentech Inc., Ipsen, Merck KGaA, Novartis AG, Novo Nordisk, Pfizer Inc., Sandoz, etc.

Key Questions Answered in This Report

  • 1. How big is the global human growth hormone market?
  • 2. What is the expected growth rate of the global human growth hormone market during 2024-2032?
  • 3. What are the key factors driving the global human growth hormone market?
  • 4. What has been the impact of COVID-19 on the global human growth hormone market?
  • 5. What is the breakup of the global human growth hormone market based on the application?
  • 6. What is the breakup of the global human growth hormone market based on the distribution channel?
  • 7. What is the breakup of the global human growth hormone market based on the route of administration?
  • 8. What are the key regions in the global human growth hormone market?
  • 9. Who are the key players/companies in the global human growth hormone market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Human Growth Hormone Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Application

  • 6.1 Growth Hormone (GH) Deficiency
    • 6.1.1 Market Trends
    • 6.1.2 Major Types
      • 6.1.2.1 Adult GH Deficiency
      • 6.1.2.2 Pediatric GH Deficiency
    • 6.1.3 Market Forecast
  • 6.2 Turner Syndrome
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Idiopathic Short Stature (ISS)
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Prader-Willi Syndrome (PWS)
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast
  • 6.5 Small for Gestational Age
    • 6.5.1 Market Trends
    • 6.5.2 Market Forecast
  • 6.6 Others
    • 6.6.1 Market Trends
    • 6.6.2 Market Forecast

7 Market Breakup by Distribution Channel

  • 7.1 Hospital Pharmacy
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Retail Pharmacy
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Online Pharmacy
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Others
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast

8 Market Breakup by Route of Administration

  • 8.1 Intravenous
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Intramuscular
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Subcutaneous
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Oral
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Competitive Landscape

  • 13.1 Market Structure
  • 13.2 Key Players
  • 13.3 Profiles of Key Players
    • 13.3.1 Eli Lilly and Company
      • 13.3.1.1 Company Overview
      • 13.3.1.2 Product Portfolio
      • 13.3.1.3 Financials
      • 13.3.1.4 SWOT Analysis
    • 13.3.2 EMD Serono Inc.
      • 13.3.2.1 Company Overview
      • 13.3.2.2 Product Portfolio
    • 13.3.3 F. Hoffmann-La Roche AG
      • 13.3.3.1 Company Overview
      • 13.3.3.2 Product Portfolio
      • 13.3.3.3 SWOT Analysis
    • 13.3.4 Ferring B.V.
      • 13.3.4.1 Company Overview
      • 13.3.4.2 Product Portfolio
      • 13.3.4.3 Financials
    • 13.3.5 Genentech Inc.
      • 13.3.5.1 Company Overview
      • 13.3.5.2 Product Portfolio
      • 13.3.5.3 SWOT Analysis
    • 13.3.6 Ipsen
      • 13.3.6.1 Company Overview
      • 13.3.6.2 Product Portfolio
      • 13.3.6.3 Financials
    • 13.3.7 Merck KGaA
      • 13.3.7.1 Company Overview
      • 13.3.7.2 Product Portfolio
      • 13.3.7.3 Financials
    • 13.3.8 Novartis AG
      • 13.3.8.1 Company Overview
      • 13.3.8.2 Product Portfolio
    • 13.3.9 Novo Nordisk
      • 13.3.9.1 Company Overview
      • 13.3.9.2 Product Portfolio
    • 13.3.10 Pfizer Inc.
      • 13.3.10.1 Company Overview
      • 13.3.10.2 Product Portfolio
      • 13.3.10.3 Financials
      • 13.3.10.4 SWOT Analysis
    • 13.3.11 Sandoz
      • 13.3.11.1 Company Overview
      • 13.3.11.2 Product Portfolio